DEC 02, 2015 8:00 AM PST

WEBINAR: Novel Psychoactive Substances: challenges and choices in forensic toxicology

Speaker
  • Chief Forensic Toxicologist, Hillsborough County Medical Examiner's Office
    Biography

      Dr. Pearson earned her B.S. in Biochemistry from the University of Wisconsin followed by a Ph.D. in Pharmacology, Toxicology and Environmental Toxicology from Michigan State University.   She is currently the Chief Forensic Toxicologist for the Hillsborough County Medical Examiner’s Office in Tampa, Florida.  Previously, she was the Chief Forensic Toxicologist for the Virginia Department of Forensic Science (9 years) and a Forensic Toxicologist with the Michigan State Police Crime Laboratory (3 years).

      Dr. Pearson has authored more than two dozen abstracts and publications, testified as an expert witness in more than 500 cases and given more than 100 presentations to law enforcement, medical and legal professionals in the areas of chemistry, toxicology, driving under the influence and drug-facilitated sexual assault.  She is board certified as a Diplomate of the American Board of Forensic Toxicology and holds adjunct faculty appointments with the Departments of Pathology and Pharmaceutical Sciences at the University of South Florida.  She is an active member of the Society of Forensic Toxicologists (SOFT) and serves as a member of the Scientific Working Group of Toxicologists (SWGTOX) to establish minimum standards of practice in forensic toxicology.  She also serves as inspector and reviewer for the American Board of Forensic Toxicology Lab Accreditation Program and is an ad hoc reviewer of manuscripts submitted for publication in the Journal of Analytical Toxicology, Forensic Science International, Journal of Drug Testing and Analysis and Journal of Clinical Toxicology.


    Abstract
    Live Webinar: December 2, 2015 8:00am PST

    In recent years, there has been a dramatic increase in the number of new designer drugs designed to mimic the effects of controlled substances.   These drugs include stimulants such cathinones (often called “bath salts”, synthetic cannabinoids (often called “spice”) and synthetic hallucinogens.  Collectively these compounds are being termed Novel Psychoactive Substances or NPS. In this presentation Dr. Julia Pearson, Chief Forensic Toxicologist for the Hillsborough County Medical Examiner’s Office, will discuss some of the new designer drugs as well as analytical approaches and a variety of mass spectral techniques that can be used to conclusively identify these substances in a forensic toxicology laboratory.

    Who Should Attend:

    Researchers, Directors and Forensic toxicologists  in the Life Sciences/Forensic Institutes/Health Care/Doping Labs/, Core Facility Personnel who are interested in learning the power of different mass spectrometry techniques in forensic labs for:

    •    Identifying novel psychoactive drugs
    •    Validated drugs of abuse analysis workflow
    •    Routine toxicology studies involving various designer drugs
    •    Getting rid of the sample backlog situation
    •    Obtaining fully defendable data in less time

    Key Learning Objectives:

    What you will learn:

    •    Effective and efficient workflow for forensic toxicology analysis
    •    Screening, quantitation and confirmation of drugs of abuse compounds
    •    Targeted and unknown screening tools and methods
    •    Unknown structure identification using Mass spectrometry techniques
    •    Identification of Isobaric compounds
    •    Full scan confirmation and multiple reaction monitoring (MRM) for quantitative results

    For forensic use only.

    Show Resources
    You May Also Like
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    APR 27, 2020 9:00 AM PDT
    C.E. CREDITS
    APR 27, 2020 9:00 AM PDT
    DATE: April 27, 2020 TIME: 9:00am PT, 12:00pm ET Recombinant adeno-associated virus (rAAV) is a small (25-nm) virus that is composed of a protein shell called a capsid and a single-stranded...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    MAY 04, 2020 9:00 AM PDT
    C.E. CREDITS
    MAY 04, 2020 9:00 AM PDT
    DATE: May 4, 2020 TIME: 9:00am PT, 12:00pm ET...
    MAR 27, 2020 11:00 AM PDT
    C.E. CREDITS
    MAR 27, 2020 11:00 AM PDT
    DATE: March 27, 2020 TIME: 11:00am PT, 2:00pm ET Adeno-associated virus (AAV) is one of the most commonly used delivery vehicles in gene therapy development. However, the presence of product...
    Loading Comments...
    Show Resources
    Attendees
    • See more